Capstan Launches, Backed By Big Names And Big Pharma, To Pioneer In Vivo Cell Therapies

Focused on Combining mRNA and CAR technologies

Two Roads
Capstan Is combining mRNA and CAR technology. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Start-Ups & SMEs

More from Business